TRAVERSA SERGIO — SEC Form 4 filings
SEC reporting owner CIK 1565832. 9 Form 4 filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-31 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 16 legs across 7 filings — 1,355,976 shares, $2,675,460 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: purchase of 272,500 shares @ $2.20 ($599,500) in RELMADA THERAPEUTICS, INC., filed 2025-11-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer, Director | 9 | 16 legs · 1,355,976 sh · $2,675,460 | — | 4 |
Form 4 filings — TRAVERSA SERGIO
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 100,000 @ $4.18 · Purchase (P): 100,000 @ $4.10 | EDGAR |
| 2025-12-16 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 27,500 @ $4.12 · Grant/award (A): 1,198,000 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 272,500 @ $2.20 | EDGAR |
| 2025-08-28 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 80,545 @ $0.62 · Purchase (P): 129,455 @ $0.67 · Purchase (P): 55,976 @ $0.74 | EDGAR |
| 2025-06-30 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 172,314 @ $0.45 · Purchase (P): 30,000 @ $0.50 · Purchase (P): 147,686 @ $0.56 | EDGAR |
| 2024-09-11 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 55,579 @ $2.71 · Purchase (P): 33,014 @ $2.75 · Purchase (P): 51,407 @ $2.99 | EDGAR |
| 2024-05-29 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Grant/award (A): 122,358 (derivative) @ $0 · Other (J): 122,358 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 31,541 @ $3.71 · Purchase (P): 40,999 @ $3.90 · Purchase (P): 27,460 @ $4.00 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1565832 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →